Sanofi India Limited, a subsidiary of the global healthcare leader Sanofi, is headquartered in Mumbai, India. Established in 1956, the company has made significant strides in the pharmaceutical industry, focusing on areas such as diabetes, cardiovascular health, and vaccines. With a strong presence across major operational regions in India, Sanofi India is committed to improving patient outcomes through innovative healthcare solutions. The company offers a diverse portfolio of core products, including insulin therapies and specialty medicines, which are distinguished by their quality and efficacy. Sanofi India has achieved notable market recognition, consistently ranking among the top pharmaceutical companies in the country. With a dedication to research and development, Sanofi India continues to advance healthcare, making a meaningful impact on the lives of patients across the nation.
How does Sanofi India Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sanofi India Limited's score of 58 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Sanofi India Limited reported total carbon emissions of approximately 9,136,160 kg CO2e for Scope 2 and about 486,630 kg CO2e for Scope 1. This reflects a decrease in Scope 2 emissions from 10,368,230 kg CO2e in 2021, while Scope 1 emissions saw a slight increase from 484,010 kg CO2e in the same year. Sanofi India Limited is a current subsidiary of Sanofi, and its emissions data is cascaded from the parent company. However, there are no specific reduction targets or climate pledges disclosed at this level. The company has not reported any Scope 3 emissions, indicating a focus on direct and indirect emissions from its operations and energy use. Overall, Sanofi India Limited is actively engaged in monitoring its carbon footprint, aligning with broader corporate sustainability initiatives set by its parent company, Sanofi.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 484,010 | 000,000 |
| Scope 2 | 10,368,230 | 0,000,000 |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sanofi India Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.